"The U.S. Food and Drug Administration today approved Tretten, Coagulation Factor XIII A-Subunit (Recombinant), the first recombinant product for use in the routine prevention of bleeding in adults and children who have a rare clotting disorder, k"...
The use of Autoplex® T, Anti-Inhibitor Coagulant Complex, Heat Treated, is contraindicated in patients with signs of fibrinolysis and in patients with disseminated intravascular coagulation (DIC).This monograph has been modified to include the generic and brand name in many instances.
Last reviewed on RxList: 1/13/2009
Additional Autoplex-T Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.